Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: Results of a cross-sectional study

被引:73
作者
Hanly, JG [1 ]
机构
[1] DALHOUSIE UNIV,HALIFAX,NS,CANADA
关键词
SLE; lupus; quality of life; damage; disease activity;
D O I
10.1177/096120339700600305
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between disease activity, cumulative damage and self-reported quality of life was examined in 96 patients with Systematic Lupus Erythematosus (SLE). Disease activity was measured by the SLE Disease Activity Index (SLEDAI) and cumulative damage by the Systematic Lupus International Cooperating Clinics/ACR damage index (DI). Quality of life was assessed by the Medical Outcomes Survey Short Form 20 (SF-20) self-report questionnaire which consists of six subscales. The study population was predominantly Caucasian (91%) and female (90%). The mean (+/- s.d.) age was 42.0 +/- 11.0 years and disease duration was 7.5 +/- 5.5 years. SLEDAI scores varied from 0-28, with a mean (+/- s.d.) of 4.8 +/- 5.2. The mean (+/- s.d.) DI score was 0.74 +/- 1.06, with a range of 0-5. Subscales of the SF-20 varied from 0-100 and the range of mean (+/- s.d.) scores varied from 35.0 +/- 42.2 to 70.5 +/- 28.7. There was no correlation between SLEDAI and DI scores or between SLEDAI scores and any of the six subscales of the SF-20. Likewise there was no correlation between DI scores and SF-20 subscales with the exception of Health perception (r = 0.34, P = 0.02). These results indicate that there are at least three independent dimensions of health status in SLE, namely disease activity, cumulative damage and quality of life. Furthermore, the extent of inflammatory disease activity and irreversible target organ damage are not the sole determinants for quality of life in SLE patients.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 23 条
  • [1] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [2] BOMBARDIERI S, 1995, LUPUS, V4, P5
  • [3] BURCKHARDT CS, 1993, J RHEUMATOL, V20, P977
  • [4] FRIES JF, 1990, QUALITY LIFE ASSESSM, P2535
  • [5] GINZLER E, 1987, J RHEUMATOL, V14, P218
  • [6] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [7] GLADMAN D, 1990, Arthritis and Rheumatism, V33, pS82
  • [8] Gladman Dafna, 1994, Arthritis and Rheumatism, V37, pS326
  • [9] GLADMAN DD, 1992, J RHEUMATOL, V19, P608
  • [10] GLADMAN DD, 1992, CURR OPIN RHEUMATOL, V3, P789